Free Trial

Karyopharm Therapeutics (KPTI) Insider Trading & Ownership

Karyopharm Therapeutics logo
$4.62 +0.01 (+0.22%)
Closing price 02:45 PM Eastern
Extended Trading
$4.49 -0.13 (-2.81%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.98%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$15.23K
Get KPTI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KPTI Insider Buying and Selling by Quarter

Karyopharm Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/23/2025Reshma RangwalaEVPSell419$6.17$2,585.23  
10/4/2024Richard A PaulsonCEOSell240$13.20$3,168.00  
8/6/2024Richard A PaulsonCEOSell240$13.95$3,348.00  
7/30/2024Stuart PoultonEVPSell192$15.90$3,052.80  
7/5/2024Richard A PaulsonCEOSell241$12.75$3,072.75  
(Data available from 1/1/2013 forward)

KPTI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI.

2.98% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings.

The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,178.60).

Insiders have purchased a total of 2,742 KPTI shares in the last 24 months for a total of $50,178.60 bought.

The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($1,224,177.30), Michael Mano ($25,016.10), Michael Mason ($52,219.50), Reshma Rangwala ($28,840.03), Richard A Paulson ($153,457.50), Sohanya Roshan Cheng ($9,855.30), and Stuart Poulton ($15,632.85).

Insiders have sold a total of 100,460 Karyopharm Therapeutics shares in the last 24 months for a total of $1,509,198.58 sold.



This page (NASDAQ:KPTI) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners